Comparison between full and biased agonist's interactions with the angiotensin II type 1 receptor (2014)
- Autores:
- Autores USP: TROSSINI, GUSTAVO HENRIQUE GOULART - FCF ; YAGUI, CARLOTA DE OLIVEIRA RANGEL - FCF
- Unidade: FCF
- Assuntos: MODELAGEM MOLECULAR; ANGIOTENSINA II
- Idioma: Inglês
- Imprenta:
- Editora: NEQUIMED (Grupo de Estudos em Química Medicinal)
- Local: São Carlos
- Data de publicação: 2014
- Fonte:
- Título do periódico: Resumos
- Nome do evento: Brazilian Symposium on Medicinal Chemistry/BrazMedChem
-
ABNT
MAGALHÃES, Juliana Gallottini de et al. Comparison between full and biased agonist's interactions with the angiotensin II type 1 receptor. 2014, Anais.. São Carlos: NEQUIMED (Grupo de Estudos em Química Medicinal), 2014. Disponível em: http://brazmedchem.iqsc.usp.br/2014/comum/doc/e-book.pdf. Acesso em: 20 abr. 2024. -
APA
Magalhães, J. G. de, Sá, M. M. de, Trossini, G. H. G., & Rangel-Yagui, C. de O. (2014). Comparison between full and biased agonist's interactions with the angiotensin II type 1 receptor. In Resumos. São Carlos: NEQUIMED (Grupo de Estudos em Química Medicinal). Recuperado de http://brazmedchem.iqsc.usp.br/2014/comum/doc/e-book.pdf -
NLM
Magalhães JG de, Sá MM de, Trossini GHG, Rangel-Yagui C de O. Comparison between full and biased agonist's interactions with the angiotensin II type 1 receptor [Internet]. Resumos. 2014 ;[citado 2024 abr. 20 ] Available from: http://brazmedchem.iqsc.usp.br/2014/comum/doc/e-book.pdf -
Vancouver
Magalhães JG de, Sá MM de, Trossini GHG, Rangel-Yagui C de O. Comparison between full and biased agonist's interactions with the angiotensin II type 1 receptor [Internet]. Resumos. 2014 ;[citado 2024 abr. 20 ] Available from: http://brazmedchem.iqsc.usp.br/2014/comum/doc/e-book.pdf - Convergent QSAR studies on a series of NK3 receptor antagonists for schizophrenia treatment
- Pharmacophore model for biased agonists of angiotensin II receptor type 1: a molecular modeling study
- Biased agonist TRV027 determinants in AT1R by molecular dynamics simulations
- In silico study of the binding mode of biased agonists of the angiotensin II type 1 receptor (AT1)
- Synthesis of inhibitors of sirtuin 2 for chagas disease
- Synthesis, molecular modeling and docking studies of nitrofurazone analogues as trypanomicine candidates
- Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides
- Building and validation of a pharmacophore model of LSD-1 inhibitors for virtual screening
- Quantitative structure-activity relationships (HQSAR, CoMFA and CoMSIA) studies for a COX-2 selective inhibitors
- Construction and validation of the CPB2.8 model and pharmacophore model design of cysteine proteases
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
